News Headlines

Or Search News in GUC Calendar

Dr. Mohamed Abdelaziz

In Alumni
Thursday, January 13, 2022

Dr. Mohamed Abdelaziz is one of the winners in 2021 Innovators Under 35 MENA – MIT Technology Review. And this is for his invention of a versatile, MR safe robotic platform to assist physicians in treating patients with cardiovascular diseases.

Worth mentioning that since 1999, MIT Technology Review has honored the young innovators whose inventions and research they find most exciting. Today that collection is Innovators Under 35, a list of technologists and scientists, all under the age of 35. Their work – spanning biomedicine, computing, communications, energy, materials, software, transportation, web and internet, and more – is changing our world.

Recently he awarded the Margaret Fishenden Centenary Memorial Prize for the best PhD thesis over the previous five-year period, in recognition of his contribution and this under the Imperial College London.

Currently Dr. Mohamed is a postdoctoral research associate at the Hamlyn Centre for Robotic Surgery in the Imperial College London, UK. He earned his PhD at the Hamlyn Centre, his master’s at the University of Twente, the Netherlands, and his bachelor’s in mechatronics engineering from the German University in Cairo, 2014.

Additionally he works as Consultant at Imperial Consultants (ICON), United Kingdom through providing consultancy services in the field of medical devices.

He approached the field of medical robotics in his last year at the GUC. He was trying to discover his passion within the field of engineering, which he studied carefully and diligently throughout the university years to be able to obtain an honors degree with honors after graduating from the university.

He awarded a full PhD scholarship from the Institute for Global Health Innovations at Imperial College London, during which he developed a safe robotic platform that helps clinicians treat patients with cardiovascular disease. The currency rooms during their treatment of patients who have problems in the arteries of the heart, such as clots and strokes.

He focused his research on this type of disease so that the device he worked on was inexpensive, used in poor areas and also to reduce the disparity between surgeons' skill levels while protecting them from radiation and improving clinical outcomes.